Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Noevir Holdings CoTSE:4928 -0.43%79 EBITDA Margin % is 14.56% as of Dec. 2025, which is 25% below its 10-year median of 19.53. GuruFocus rates TSE:4928 with a GF Score™ of 79/100 and a GF Value™ of 円5,265.32 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,958 Consumer Packaged Goods companies, Noevir Holdings Co ranks better than 77.99% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Noevir Holdings Co's EBITDA for the
three
months ended in Dec. 2025 was 円2,252 Mil. Noevir Holdings Co's Revenue for the
three
months ended in Dec. 2025 was 円15,466 Mil. Therefore, Noevir Holdings Co's EBITDA margin for the quarter that ended in Dec. 2025 was 14.56%.
Noevir Holdings Co (TSE:4928) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Noevir Holdings Co EBITDA Margin % Related Terms
Noevir Holdings Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Noevir Holdings Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4928 vs PG, CL, KVUE: EBITDA Margin % Comparison
For the Household & Personal Products subindustry, Noevir Holdings Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noevir Holdings Co EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Noevir Holdings Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Noevir Holdings Co (TSE:4928) has a EBITDA Margin % of 14.56% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Noevir Holdings Co and its competitors. This is 25% below median its historical median of 19.53. Over the past decade, Noevir Holdings Co's EBITDA Margin % has ranged from 17.13 to 23.32. According to the industry distribution chart, Noevir Holdings Co ranks #431 out of 1958 companies in the Consumer Packaged Goods industry, placing it in the top 22%.
Is Noevir Holdings Co's EBITDA Margin % too high?
Noevir Holdings Co's current EBITDA Margin % of 14.56% is 25% below median its 10-year median of 19.53. Over the past 10 years, this metric has ranged from a low of 17.13 to a high of 23.32. The Consumer Packaged Goods industry median EBITDA Margin % is 8.98. Noevir Holdings Co's value of 14.56% is 62.1% above this industry median. Based on the distribution chart, Noevir Holdings Co ranks #431 out of 1958 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Noevir Holdings Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Noevir Holdings Co ranks #431 out of 1958 companies for EBITDA Margin %. This places Noevir Holdings Co in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.98. Noevir Holdings Co's value of 14.56% is 62.1% above this benchmark. Historically, Noevir Holdings Co's own EBITDA Margin % has ranged from 17.13 to 23.32 over the past decade. While the company's 10-year median is 19.53 vs. the industry median of 8.98, Noevir Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.98, based on 1,958 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Noevir Holdings Co's current EBITDA Margin % of 14.56% is 62.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Noevir Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Noevir Holdings Co's current EBITDA Margin % is 14.56%, which is 25% below median its own 10-year median of 19.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,265.32, compared to a current price of 円4,585.00 — trading 12.9% below its estimated fair value. The current EBITDA Margin % is 14.56%, which is 25% below median its 10-year median of 19.53 and 62.1% above the Consumer Packaged Goods industry median of 8.98. Noevir Holdings Co's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current EBITDA Margin % is 14.56% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?
Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued.
The current stock price of 円4,585.00 is trading 12.9% below its estimated GF Value™ of 円5,265.32.
GuruFocus considers Noevir Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:4928:
EBITDA Margin %: 14.56% (25% below median its 10-year median of 19.53)
GF Value™: 円5,265.32 vs. price of 円4,585.00 (12.9% below fair value)
Industry Position: 62.1% above the Consumer Packaged Goods median (#431 of 1958)
No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
79GF Score
Get the complete analysis for TSE:4928
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4928 has been successfully added to your 
